US$ 26.20
bpc 157 pubmed tendon Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions BPC-157: Why Women Are Asking
Description
The compound's primary target, NNMT, sits at a critical metabolic intersection where NAD+ precursor availability meets cellular methylation capacity

Not an unusual scenario

In medial collateral ligament (MCL) injury models, BPC-157 administered intraperitoneally (10 g or 10 ng/kg once daily), topically as a cream layer, or orally in drinking water consistently produced functional, biomechanical, macroscopic, and histological healing improvements throughout the 90-day study period

We, however, also used vitamin B6
